Home / Business and Economy / Dragons' Den Duo Turn £75k Into £11M
Dragons' Den Duo Turn £75k Into £11M
6 Apr
Summary
- Entrepreneurs secured £75k investment for 2.5% equity.
- Omni's sales reached £8.4 million in the year post-show.
- Founders aimed to create an Ozempic-style medication for dogs.
Practicing UK veterinarian Dr. Guy Sandelowsky and co-founder Shiv Sivakumar have achieved an astonishing £11 million in revenue within a year of securing a £75,000 investment on Dragons' Den. The pair pitched their pet health brand, Omni, and successfully gained investment from Steven Bartlett and Deborah Meaden in February 2025, parting with 2.5% of their company.
Founded six years ago, Omni experienced significant growth following their appearance on the BBC show. The brand attracted 100,000 new customers and reported £8.4 million in sales in the year after their Dragon's Den debut. This follows previous sales of £2.7 million in 2024 and £1.2 million in 2023. Omni specializes in supplements for common pet issues and sustainable pet food, with ambitions to develop an Ozempic-style medication for canine obesity.
The entrepreneurs shared their insights on securing a Dragons' Den spot, emphasizing authenticity, knowing financial numbers, and thorough preparation. This was their third attempt to get on the show, highlighting their persistence and dedication. The investment process involved rigorous due diligence, with the Dragons' teams meticulously verifying all claims made by Omni.
Dragons Steven Bartlett and Deborah Meaden have been actively involved, providing support and strategic guidance. Deborah Meaden expressed her satisfaction with Omni's high-quality, vet-formulated products, noting that her own dogs enthusiastically approved of the food and treats, solidifying her investment decision. The partnership aims to further propel Omni's success in the pet wellness market.
